139 related articles for article (PubMed ID: 25025148)
1. Design, synthesis and biological evaluation of C6-modified celastrol derivatives as potential antitumor agents.
Tang K; Huang Q; Zeng J; Wu G; Huang J; Pan J; Lu W
Molecules; 2014 Jul; 19(7):10177-88. PubMed ID: 25025148
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3- and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities.
Shan WG; Wang HG; Chen Y; Wu R; Wen YT; Zhang LW; Ying YM; Wang JW; Zhan ZJ
Bioorg Med Chem Lett; 2017 Aug; 27(15):3450-3453. PubMed ID: 28587825
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity evaluation of novel ursolic acid derivatives.
Meng YQ; Zhang LF; Liu DY; Liu LW; Zhang Y; Zhao MJ
J Asian Nat Prod Res; 2016; 18(3):280-8. PubMed ID: 26524942
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Urea Derivatives of Celastrol as Selective Peroxiredoxin 1 Inhibitors against Colorectal Cancer Cells.
Li Y; Zhu Y; Shang FF; Xu L; Jiang D; Sun B; Zhang L; Luo C; Zhang A; Zhang H; Ding C
J Med Chem; 2024 May; 67(9):7176-7196. PubMed ID: 38679872
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds.
Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
Eur J Med Chem; 2017 Oct; 139():836-848. PubMed ID: 28865279
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and cytotoxicity of cell death mechanism of rotundic acid derivatives.
He YF; Nan ML; Sun JM; Meng ZJ; Li W; Zhang M
Bioorg Med Chem Lett; 2013 May; 23(9):2543-7. PubMed ID: 23558236
[TBL] [Abstract][Full Text] [Related]
9. Novel rotundic acid derivatives: synthesis, structural characterization and in vitro antitumor activity.
Chen Y; He YF; Nan ML; Sun WY; Hu J; Cui A; Li F; Wang F
Int J Mol Med; 2013 Feb; 31(2):353-60. PubMed ID: 23233042
[TBL] [Abstract][Full Text] [Related]
10. Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers.
Zhou Y; Li X; Chen K; Ba Q; Zhang X; Li J; Wang J; Wang H; Liu H
Eur J Med Chem; 2021 Feb; 211():113000. PubMed ID: 33261896
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol.
Huang Y; Zhou D; Hang T; Wu Z; Liu J; Xu Q; Xie X; Zuo J; Wang Z; Zhou Y
Anticancer Drugs; 2012 Jun; 23(5):515-24. PubMed ID: 22343423
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antitumor evaluation of novel celastrol derivatives.
Xu M; Li N; Zhao Z; Shi Z; Sun J; Chen L
Eur J Med Chem; 2019 Jul; 174():265-276. PubMed ID: 31051401
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model.
Li Z; Wu X; Li J; Yao L; Sun L; Shi Y; Zhang W; Lin J; Liang D; Li Y
Int J Nanomedicine; 2012; 7():2389-98. PubMed ID: 22661892
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of 28-amide derivatives of 23-hydroxy betulinic Acid as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Med Chem; 2013 Nov; 9(7):920-5. PubMed ID: 23083117
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of Celastrol Derivatives with Improved Cytotoxic Selectivity and Antitumor Activities.
Hu XL; He QW; Long H; Zhang LX; Wang R; Wang BL; Feng JH; Wang Q; Hou JQ; Zhang XQ; Ye WC; Wang H
J Nat Prod; 2021 Jul; 84(7):1954-1966. PubMed ID: 34170694
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterisation of celastrol derivatives as potential anticancer agents.
Zhang HJ; Zhang GR; Piao HR; Quan ZS
J Enzyme Inhib Med Chem; 2017 Dec; 33(1):190-198. PubMed ID: 29231066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
